Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Europe Artificial Retina Market: By Implant Type, By Disease Type, By End Users and Country
Europe Artificial Retina Market: By Implant Type, By Disease Type, By End Users and Country
Europe Artificial Retina Market size was valued at US$ X million in 2023 and is poised to grow at a CAGR of x from 2024-2030. Artificial retina is the medical device consists an array of microelectrodes. These devices are implanted into eyes of people those are blind due to the retinal disease. These devices are used in the retinal degenerative disease that causes the damage of photoreceptor cells of retina and leads to complete vision loss. Majorly occurring retinal degenerative diseases include retinitis pigmentosa and age-related macular degeneration. Retinal implants are made up of carbon nanotube biomimetic film with a transmitter and video processing units. These devices restore the vision by capturing light, convert into electrical signals and form an image by stimulating the neurons in retina.
Drivers: Increase in the prevalence of vision impaired patients Adoption of newer devices Increase in the R&D for the innovation of newer devices Restraints: Stringent regulatory policies for product approval Product recall High R&D expenditure
|
Report Benchmarks |
Details |
|
By Implant type |
|
|
By Disease type |
|
|
By End User |
|
Download Free Sample Report
The europe artificial retina market size was valued at US$ X million in 2023 and is poised to grow at a CAGR of x from 2024-2030
The report europe artificial retina market data: Europe (Germany, France, Italy, Spain, and United Kingdom (UK)
The key players of europe artificial retina market report.second sight medical products, inc. retina implant ag nidek co. ltd. intelligent medical implants pixium vision
| 1.Executive Summary |
| 2. Europe Artificial Retina Market Introduction |
| 2.1. Europe Artificial Retina Market - Taxonomy |
| 2.2. Europe Artificial Retina Market - Definitions |
| 2.2.1.Implant type |
| 2.2.2.Disease type |
| 2.2.3.End User |
| 2.2.4.Country |
| 3. Europe Artificial Retina Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Europe Artificial Retina Market Analysis, 2019- 2023 and Forecast 2024 -2030 |
| 4.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Europe Artificial Retina Market By Implant type, 2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 5.1. Epiretinal Implants |
| 5.1.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Subretinal Implants |
| 5.2.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Europe Artificial Retina Market By Disease type, 2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 6.1. Retinitis Pigmentosa |
| 6.1.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Age-related Macular Degeneration |
| 6.2.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Others |
| 6.3.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Europe Artificial Retina Market By End User, 2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Clinics |
| 7.2.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Ambulatory Surgical Centers |
| 7.3.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Europe Artificial Retina Market By Country, 2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 8.1. Germany |
| 8.1.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. France |
| 8.3.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Italy |
| 8.4.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. United Kingdom (UK) |
| 8.5.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Spain |
| 8.6.1. Market Analysis, 2019- 2023 and Forecast, 2024 -2030, (Sales Value USD Million) |
| 8.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.6.3. Market Opportunity Analysis |
| 9.Germany Europe Artificial Retina Market ,2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 9.1. Implant type Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Epiretinal Implants |
| 9.1.2.Subretinal Implants |
| 9.2. Disease type Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Retinitis Pigmentosa |
| 9.2.2.Age-related Macular Degeneration |
| 9.2.3.Others |
| 9.3. End User Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Clinics |
| 9.3.3.Ambulatory Surgical Centers |
| 10.Europe Europe Artificial Retina Market ,2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 10.1. Implant type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Epiretinal Implants |
| 10.1.2.Subretinal Implants |
| 10.2. Disease type Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Retinitis Pigmentosa |
| 10.2.2.Age-related Macular Degeneration |
| 10.2.3.Others |
| 10.3. End User Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Clinics |
| 10.3.3.Ambulatory Surgical Centers |
| 11.France Europe Artificial Retina Market ,2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 11.1. Implant type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Epiretinal Implants |
| 11.1.2.Subretinal Implants |
| 11.2. Disease type Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Retinitis Pigmentosa |
| 11.2.2.Age-related Macular Degeneration |
| 11.2.3.Others |
| 11.3. End User Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Clinics |
| 11.3.3.Ambulatory Surgical Centers |
| 12.Italy Europe Artificial Retina Market ,2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 12.1. Implant type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Epiretinal Implants |
| 12.1.2.Subretinal Implants |
| 12.2. Disease type Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Retinitis Pigmentosa |
| 12.2.2.Age-related Macular Degeneration |
| 12.2.3.Others |
| 12.3. End User Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Clinics |
| 12.3.3.Ambulatory Surgical Centers |
| 13.United Kingdom (UK) Europe Artificial Retina Market ,2019- 2023 and Forecast 2024 -2030 (Sales Value USD Million) |
| 13.1. Implant type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Epiretinal Implants |
| 13.1.2.Subretinal Implants |
| 13.2. Disease type Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Retinitis Pigmentosa |
| 13.2.2.Age-related Macular Degeneration |
| 13.2.3.Others |
| 13.3. End User Analysis 2019- 2023 and Forecast 2024 -2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Clinics |
| 13.3.3.Ambulatory Surgical Centers |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Second sight Medical Products, Inc. |
| 14.2.2.Retina Implant AG |
| 14.2.3.Nidek co. Ltd. |
| 14.2.4.Intelligent Medical implants |
| 14.2.5.Pixium Vision |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.